Aarti Group of Companies has extended financial assistance of ₹11 lakh under its Corporate Social Responsibility (CSR) initiative to support the purchase of medicines for thalassemia patients, reinforcing the company’s commitment to healthcare and community welfare.
The contribution has been made as part of the company’s ongoing CSR efforts aimed at improving access to essential healthcare for individuals suffering from chronic medical conditions. The financial assistance will be utilised to procure medicines required for the treatment and management of thalassemia patients.
Thalassemia is a hereditary blood disorder that requires lifelong medical care, including regular blood transfusions and continuous medication. The cost of treatment often places a significant financial burden on patients and their families, making corporate support an important source of assistance.
Through this initiative, Aarti Group seeks to ease the treatment expenses of affected patients while contributing to better healthcare outcomes within the community.
The company stated that the initiative reflects its broader commitment to public health, social responsibility and community development. By supporting access to essential medicines, Aarti Group aims to improve the quality of life of patients requiring long-term treatment.
Corporate Social Responsibility initiatives focused on healthcare continue to play a crucial role in complementing public health efforts by supporting medical infrastructure, patient care, disease awareness and access to treatment for vulnerable sections of society.
Aarti Group has been actively involved in various CSR programmes covering healthcare, education, environmental sustainability and community development, reaffirming its commitment to creating a positive social impact beyond its business operations.
The latest contribution for thalassemia patients highlights the growing role of corporate participation in strengthening healthcare support systems and improving access to life-saving treatment for those in need.
Disclaimer: This report has been editorially prepared using publicly available information and official statements. Readers are advised to refer to official announcements from Aarti Group for further details.
